Buy Ribociclib 200mg Online

We are excited to introduce Ribociclib 200mg, a powerful medication used in the treatment of advanced breast cancer. With our discreet worldwide delivery service, you can conveniently access Ribociclib 200mg from the comfort of your own home.

Product Name: Ribociclib 200mg

Generic Name: Ribociclib

Manufacturer: Novartis Pharmaceuticals

What is Ribociclib 200mg?

Ribociclib 200mg is an oral targeted therapy medication used in the treatment of hormone receptor-positive, HER2-negative advanced breast cancer. It belongs to a class of drugs known as cyclin-dependent kinase (CDK) 4/6 inhibitors. Ribociclib is designed to specifically target and inhibit the activity of CDK 4 and CDK 6 enzymes, which play a critical role in promoting cancer cell growth.

How does Ribociclib 200mg work?

Ribociclib works by blocking the CDK 4/6 enzymes, which are involved in regulating the cell cycle and cell division. By inhibiting these enzymes, Ribociclib helps to slow down the growth and division of cancer cells, thereby reducing the progression of advanced breast cancer. It is typically used in combination with other hormone therapies, such as aromatase inhibitors, to provide an effective treatment approach.

Benefits of Ribociclib 200mg:

1. Enhanced Treatment Efficacy: Ribociclib 200mg, when used in combination with hormone therapies, has shown significant benefits in improving progression-free survival and overall survival in patients with advanced breast cancer.
2. Hormone Receptor-Positive Breast Cancer: Ribociclib is particularly effective in treating hormone receptor-positive, HER2-negative breast cancer, which accounts for a significant percentage of breast cancer cases.
3. Well-Tolerated: Ribociclib 200mg has been well-tolerated by patients, and its side effects are generally manageable with appropriate medical supervision.

Why choose Equicurepharm for Ribociclib 200mg?

1. Authenticity: Equicurepharm is committed to providing genuine medications. We source Ribociclib 200mg directly from reputable manufacturers, ensuring its authenticity and quality.
2. Discreet Worldwide Delivery: We offer discreet worldwide delivery, ensuring your privacy throughout the ordering and shipping process.
3. Customer Support: Our dedicated customer support team is available to assist you with any questions or concerns you may have, providing guidance and assistance throughout your treatment journey.

Please Note:

• Ribociclib 200mg is a prescription medication. It is essential to consult with a healthcare professional who will evaluate your condition and determine if Ribociclib is suitable for you.
• Side effects may occur with the use of Ribociclib 200mg, and it is important to discuss potential risks and benefits with your healthcare provider.
• Keep Ribociclib 200mg out of reach of children and store it as per the instructions provided.

At Equicurepharm, your health and well-being are our top priorities. We strive to provide you with the highest quality medications, including Ribociclib 200mg, along with discreet worldwide delivery. Place your order today and experience the convenience of accessing premium pharmaceutical products from the comfort of your own home.

Brand:: Ribociclib 200mg
Salt::: Ribociclib 200mg
Dosage::: 200mg
Packaging Type:: Box
Packaging Size::: 21 tablets

DESCRIPTION

What is Kisqali (ribociclib) for?

Kisqali (ribociclib) is a kinase inhibitor indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer1,2.

How does Kisqali (ribociclib) work?

Ribociclib 200mg is an inhibitor of cyclin-dependent kinase (CDK) 4 and 6. Before a cell can divide, it has to go through four phases: a growth phase (G1-phase), a synthesis phase (S-phase), another growth phase (G2-phase), and a last phase is where the cell divides (M-phase). Cancer cells divide exceedingly fast, passing through these 4 phases rapidly. Ribociclib blocks the progression from the first G1-phase, into the second S-phase. It does this by inhibiting the cyclin-dependent kinases 4 and 6 (CDK4 and CDK6) – two proteins that are involved in entering the S-phase1.

Where has Kisqali (ribociclib) been approved?

Kisqali (ribociclib) was approved in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with HR-positive HER2-negative advanced or metastatic breast cancer by:

FDA (USA) on March 13, 20173

EMA (EU) on August 22, 20174

TGA (Australia) on October 23, 20175

Health Canada on April 27, 20186

How is Kisqali (ribociclib) taken?

The standard dosage is:

600 mg orally (three 200 mg tablets) taken once daily with or without food for 21 consecutive days, followed by 7 days off treatment (one complete cycle consists of 28 days).

Dose interruption, reduction, and/or discontinuation may be required based on individual safety and tolerability.

Complete information about Kisqali (ribociclib) dosage and administration can be found in the resources section.

Consult your treating doctor for personalised dosing.

Are there any known adverse reactions or side effects of Kisqali (ribociclib)

Most common adverse reactions (incidence ≥ 20%) are1,4:

low levels of white blood cells
nausea
fatigue
diarrhea
alopecia
vomiting
constipation
headache
back pain.